CF Industries
CF
$122.31
-1.07%
CF Industries Holding, Inc. is a leading global producer and distributor of nitrogen-based fertilizers, operating primarily in the Agricultural Inputs industry within the Basic Materials sector. The company is distinguished as a low-cost leader, leveraging its access to North American natural gas feedstock to maintain a competitive advantage in nitrogen production. The current investor narrative is dominated by a significant geopolitical catalyst, as the recent closure and subsequent reopening of the Strait of Hormuz has created extreme volatility in energy and fertilizer markets, positioning CF Industries as a direct beneficiary of supply chain disruptions and shifting global trade flows for nitrogen products.…
CF
CF Industries
$122.31
CF 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CF Industries's 12-month outlook, with a consensus price target around $159.00 and implied upside of +30.0% versus the current price.
Average Target
$159.00
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$98 - $159
Analyst target range
Analyst coverage for CF Industries is limited, with only 5 analysts providing estimates, indicating this is a stock with less institutional research focus which can lead to higher volatility and less efficient price discovery. The average estimated EPS for the period is $7.37, with a wide range from a low of $6.14 to a high of $9.48, reflecting significant uncertainty about future earnings, likely tied to volatile nitrogen prices and geopolitical factors. No consensus price target or recommendation data is provided in the dataset, making a precise upside/downside calculation impossible. The wide range in EPS estimates, spanning from $6.14 to $9.48, signals high uncertainty among the covering analysts. The high-end estimate of $9.48 likely assumes sustained high nitrogen prices and margin expansion from the geopolitical supply shock, while the low-end estimate of $6.14 may factor in a rapid normalization of fertilizer markets and input cost pressures. Recent institutional rating actions show a split sentiment, with firms like Mizuho downgrading to 'Underperform' in March 2026, while BMO Capital and Wells Fargo maintain 'Outperform' and 'Overweight' ratings, respectively. This divergence in analyst views underscores the contentious and uncertain investment case driven by external commodity and geopolitical forces.
Bulls vs Bears: CF Investment Factors
The investment case for CF Industries is a classic tension between deep cyclical value and the imminent risk of a cyclical peak. The bull case is compellingly supported by exceptional current profitability (20.54% net margin, 30.07% ROE), robust free cash flow ($1.80B TTM), and a valuation (8.62x trailing P/E) that appears to price in a severe downturn. However, the bear case is gaining strength, anchored by the reversal of its key geopolitical catalyst (Hormuz reopening) and the market's clear expectation of earnings normalization, as evidenced by the 54% premium of its forward P/E (13.25x) over its trailing multiple. The single most important tension is the duration and magnitude of the earnings decline from recent super-normal levels. If CF can sustain margins better than feared, the stock is deeply undervalued; if earnings collapse toward the analyst low estimate of $6.14, the current price offers little margin of safety.
Bullish
- Exceptional Profitability & ROE: CF's trailing twelve-month net margin of 20.54% and return on equity of 30.07% are exceptionally high for a capital-intensive commodity producer, indicating superior capital efficiency. This is underpinned by a low-cost production advantage from North American natural gas feedstock.
- Strong Free Cash Flow Generation: The company generated $1.80 billion in trailing twelve-month free cash flow, providing significant financial flexibility. This robust cash generation supports shareholder returns through dividends and buybacks, and funds investments in growth initiatives like blue and green ammonia.
- Attractive Valuation on Trailing Metrics: With a trailing P/E of 8.62x and a PEG ratio of 0.26, the stock appears deeply undervalued relative to its recent earnings and growth. The P/E sits near the bottom of its historical range, which has seen multiples above 25x, suggesting a potential value opportunity if earnings stabilize.
- Solid Balance Sheet & Liquidity: A strong current ratio of 3.37 and a manageable debt-to-equity ratio of 0.82 provide a defensive financial foundation. This reduces refinancing risk and provides a buffer against the cyclical downturns inherent in the fertilizer industry.
Bearish
- Earnings Normalization & Forward P/E Spike: The forward P/E of 13.25x is significantly higher than the trailing P/E of 8.62x, indicating the market expects a sharp earnings decline from recent cyclical highs. Analyst EPS estimates for the next period average $7.37, a substantial drop from the recent quarterly run-rate.
- Geopolitical Catalyst Reversal Risk: Recent news confirms the Strait of Hormuz has reopened, removing the primary geopolitical risk premium that fueled the rally. This directly threatens the supply-driven margin expansion narrative and could lead to a rapid normalization of fertilizer prices and CF's profitability.
- High Cyclicality & Price Volatility: Revenue and earnings exhibit significant quarter-to-quarter variability (e.g., Q2 2025 revenue of $1.89B vs. Q3's $1.66B), reflecting the commodity-driven nature of the business. The stock's 52-week range from $75.42 to $141.96 underscores its extreme sensitivity to nitrogen price swings.
- Limited Analyst Coverage & High Uncertainty: Only 5 analysts cover the stock, leading to less efficient price discovery and higher volatility. Their EPS estimates show extreme divergence, with a low of $6.14 and a high of $9.48, reflecting profound uncertainty about the post-catalyst earnings trajectory.
CF Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 56.44% gain over the past year. With a current price of $120.93, the stock is trading at approximately 85% of its 52-week high of $141.96, indicating strong momentum but also proximity to a key resistance level that could signal overextension. The stock is far from its 52-week low of $75.42, suggesting the recent run-up has been substantial and leaves limited room for error without a significant correction. Recent momentum shows signs of volatility and potential exhaustion, with the stock down 5.60% over the past month, diverging sharply from the strong 1-year uptrend. This contrasts with a still-robust 30.91% gain over the past three months, indicating the recent pullback may be a temporary consolidation or profit-taking event following a parabolic move. The stock's beta of 0.516 indicates it has been significantly less volatile than the broader market during this period, which is unusual for a commodity stock experiencing such a dramatic price surge. Key technical support is anchored at the 52-week low of $75.42, while immediate resistance sits at the recent high of $141.96. A decisive breakout above $142 would signal a continuation of the powerful bull trend, whereas a sustained breakdown below the recent low of $75.42 would invalidate the uptrend. The stock's low beta of 0.516 suggests it has exhibited only about half the volatility of the S&P 500, which is a critical consideration for risk management, especially given the commodity-driven nature of its business and recent geopolitical price spikes.
Beta
0.52
0.52x market volatility
Max Drawdown
-25.8%
Largest decline past year
52-Week Range
$75-$142
Price range past year
Annual Return
+53.6%
Cumulative gain past year
| Period | CF Return | S&P 500 |
|---|---|---|
| 1m | -10.4% | +12.2% |
| 3m | +31.3% | +2.3% |
| 6m | +47.7% | +4.7% |
| 1y | +53.6% | +29.2% |
| ytd | +52.6% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CF Fundamental Analysis
CF Industries is experiencing robust revenue growth, with its most recent quarterly revenue (Q4 2025) reaching $1.87 billion, representing a 22.83% year-over-year increase. This growth is part of a strong multi-quarter trend, with sequential quarterly revenues for 2025 at $1.66B (Q1), $1.89B (Q2), $1.66B (Q3), and $1.87B (Q4), indicating cyclical strength but some quarter-to-quarter variability typical of the fertilizer industry. The revenue segment data shows Ammonia as the largest contributor at $708 million for the period, followed by UAN at $564 million, Urea at $372 million, and AN at $81 million, providing a clear view of the product mix. The company is highly profitable, with Q4 2025 net income of $404 million and a gross margin of 41.08%. Profitability has been strong and consistent, with net income margins for the last four quarters of 2025 at 18.76% (Q1), 20.42% (Q2), 21.28% (Q3), and 21.58% (Q4), demonstrating stable to slightly expanding profitability. The trailing twelve-month net margin stands at 20.54%, which is healthy for a capital-intensive commodity producer. The balance sheet is solid, with a strong current ratio of 3.37 and a manageable debt-to-equity ratio of 0.82. The company is a significant cash flow generator, with free cash flow over the trailing twelve months of $1.80 billion, providing ample internal funding for growth, dividends, and share repurchases. The return on equity of 30.07% is exceptionally high, indicating efficient use of shareholder capital, while the return on assets of 10.63% reflects solid operational efficiency.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.22%
YoY Comparison
Gross Margin
+0.41%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CF Overvalued?
Given the company's substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 8.62x, while the forward PE is 13.25x, based on estimated EPS of $7.37. The significant gap between trailing and forward multiples suggests the market anticipates a normalization of earnings from recent cyclical highs, as the forward multiple implies lower future earnings relative to the current price. Compared to industry averages, CF's valuation presents a mixed picture. Its trailing PE of 8.62x is below the sector average implied by its own historical context, which often saw PEs in the teens during strong cycles. The Price-to-Sales ratio of 1.77x and EV/EBITDA of 4.41x appear modest, suggesting the market is not assigning a significant growth premium despite the recent geopolitical tailwinds. The PEG ratio of 0.26, based on trailing metrics, indicates the stock is cheap relative to its growth rate, though this metric can be volatile for cyclical companies. Historically, the stock's current trailing PE of 8.62x sits near the lower end of its own historical range observed in the provided data, which has seen PEs fluctuate from as low as 3.83x (June 2022) to over 25x during weaker earnings periods. Trading near the bottom of its historical PE band suggests the market may be pricing in a sharp earnings decline or viewing recent profitability as a cyclical peak, rather than a sustained new level, creating a potential value opportunity if the earnings cycle is longer than anticipated.
PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -16x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CF's primary risk is the extreme cyclicality of its earnings, which are directly tied to volatile nitrogen fertilizer prices. The recent quarterly net income margin expansion from 18.76% to 21.58% in 2025 is likely unsustainable, and the forward P/E of 13.25x signals an expected sharp decline. While the balance sheet is strong (D/E of 0.82), a prolonged downturn could pressure the dividend (2.6% yield) and share buybacks, which have been supported by exceptional but potentially fleeting free cash flow. Revenue concentration in nitrogen products (Ammonia, UAN, Urea) leaves it exposed to a single commodity cycle without meaningful diversification.
Market & Competitive Risks: The stock faces significant valuation compression risk as its primary geopolitical tailwind has reversed with the reopening of the Strait of Hormuz. Trading at 85% of its 52-week high, the stock is vulnerable to a derating if fertilizer prices normalize swiftly. Its low beta of 0.516 is anomalous for a commodity stock and may increase if it reverts to higher correlation with energy and agricultural inputs. Competitive risks are moderated by its low-cost producer status, but the industry remains fragmented and subject to global trade flows and new capacity additions that could pressure margins.
Worst-Case Scenario: The worst-case scenario involves a rapid and severe normalization of global nitrogen fertilizer markets following the Hormuz reopening, combined with a decline in North American natural gas prices that compresses CF's feedstock advantage. This could trigger analyst downgrades (like Mizuho's recent 'Underperform'), earnings falling to the low estimate of $6.14, and a multiple contraction toward the bottom of its historical range. A realistic downside could see the stock re-test its 52-week low of $75.42, representing a potential loss of approximately -38% from the current price of $120.93. A drawdown of this magnitude is consistent with the stock's historical volatility and the -25.75% max drawdown observed in the recent data.